Taiya Technology and Aliyun reach comprehensive cooperation to jointly build a new ecosystem for clinical trial AI.

According to the information from Taige Pharmaceuticals, on April 16, 2026, a senior delegation from Taige Pharmaceuticals and its subsidiary, Hangzhou Taiya Language Technology Co., Ltd., visited and exchanged ideas at Alibaba Cloud's Yun Valley Park. The purpose of this visit is to further strengthen the interaction between the two parties in the field of cutting-edge technology. The two sides had in-depth discussions on the application prospects of artificial intelligence technology in clinical trials, and announced that they will launch comprehensive cooperation in this field. In the future, Taiya Technology will work together with Alibaba Cloud to explore the integration of cutting-edge technology and medical research and development, aiming to use artificial intelligence technology to improve the efficiency and quality of clinical trials, and promote the intelligent transformation of the pharmaceutical industry.